Pinned Tweet
Monogenic autoinflammatory diseases tended to be defined by specific cytokines, such as IL-1b, IL-6, TNF and type I IFN. However, the condition APLAID did not fit, and instead we find that it may be the first of a new category that are caused by G-CSF. rdcu.be/c8Mrs
seth masters retweeted
Baker, @sethmasters et al. identify a 13-year-old male with complex symptoms including those consistent with familial chilblain lupus. This inborn error of immunity is due to a genomic translocation resulting in SAMHD1 deficiency hubs.la/Q04vqg1Y0
#Autoinflammation
seth masters retweeted
Dear Everyone, I've read the #NHMRC draft strategy and I have notes ...
So I'm going to...🧵🤔🧵😱🧵😵💫🧵🙏🧵🧵🧵
#NHMRCdraftStratergy #Ihavenotes #ValueFundamentalScience
seth masters retweeted
🔊 🗓️ SAVE THE DATE
ASI Innate Immunity SIG and Australian Inflammation Centres as well as Australasian Cell Death Society jointly host a symposium on 10-11 Nov at the University of Adelaide.
More details to come.
#ASImmunology
#innateimmunity #inflammation #celldeath
A large dataset we hope is helpful for patients who may have CAPS, an #autoinflammatory condition associated with gene variants in NLRP3. Many variants of uncertain significance now have a readout from our in vitro assay which can aid clinical diagnosis. rdcu.be/d9iRG
We tested this library of NLRP3 variants in response to stimulation, at low temperature (some patients with CAPS have temperature sensitive flares), and in response to a NLRP3 inhibitor, all of which yielded interesting results. If you have another idea, we are happy to share!
Amazing work by first author
@shouya_feng
with the support of many others, thanks all!!!
A starter pack for anyone interested in #autoinflammation and #autoinflammatory diseases.
Please let me know if you’d like to be added.
go.bsky.app/5M6obrp
Most certainly in my calendar! Miss this chance and the next one is not till 2027!
We are delighted to invite you to the 13th Meeting of the International Society of Systemic Autoinflammatory Diseases (ISSAID), which will take place in Paris from April 8th to 10th, 2025.
▶️
issaid.org/issaid2025/
@HelenLachmann @AAlliance_SAID @_ERNRITA @contactfai2r
seth masters retweeted
Come along to our #StudentOpenDay & take your research degree in biomedicine & clinical sciences to the next level
Thurs 15th August
5-7pm
Auditorium, Level 4, Green Chemical Futures Building, 13 Rainforest Walk, Monash University, Main Clayton Campus
➡️ bit.ly/3qe6em0
seth masters retweeted
Also! I'm recruiting for a...
Post doc: aurecruitment.actionhrm.com/…
And an
RA: aurecruitment.actionhrm.com/…
If you're interested in discovering weird and wonderful triggers of inflammation in #neurodevelopmentaldisorder, #neurodegeneration and #inflammatorydisease please apply
Our laboratory is hiring at the Postdoc or RA level! If Innate Immunology and Autoinflammatory Disease are of interest to you consider to join us @Hudson_Research in Melbourne Australia!
seek.com.au/job/77002348
seek.com.au/job/77007854
We found mutations in UNC93B1 can cause early-set lupus, also reported by @barton_lab Min Ae Lee-Kirsch @MajerOlivia and colleagues, likely many more patients yet to be diagnosed.
nature.com/articles/s41590-0…
UNC93B1 variants don't seem very spontaneously active
- Tend to be hyper-responsive to TLR7/8, would blocking a single TLR in vivo be therapeutic?
- Is there an endogenous or infectious trigger?
- Different mutations, different mechanisms?
TLDR - associated "Research Briefing" for our article. nature.com/articles/s41590-0…
IL-18 as a contributor to renal involvement in lupus-like disease, an interesting proposal based on an NLRC4 Gain-of-Function Mutation by @AlexandreBelot and colleagues kireports.org/article/S2468-…
There was one big update in this publication by @science_sophie since the preprint - a second patient with the same dominant negative mutation in Otulin, contributed by @jqanatish and others from the King Abdullah Children’s Hospital in Riyadh. 🙏 all!
In @JExpMed, Davidson, Shibata, @komander_lab @sethmasters @WEHI_research et al identify a novel dominant negative heterozygous mutation in OTULIN (p.Cys129S) that enhances cell death & inflammatory signaling, thereby driving autoinflammatory disease. hubs.la/Q02t8-B50
No surprise I can't remember those TLR9 siRNA experiments...
rdcu.be/dCHcO
seth masters retweeted
The registration website for our upcoming Inflammasome EMBO Workshop on September 24-27, 2024 is now live. Check out the fantastic line-up of speakers who will be joining us 🤩.
Also, lots of opportunities for short talks available!
meetings.embo.org/event/24-i…
seth masters retweeted
We have an open Melbourne-based #PhD position in the @sethmasters lab @Hudson_Research & the @IsbBonn @UniBonn. The project focusses on the role of the inflammasome in the context of autoinflammatory diseases. For more info see👉bit.ly/3S3e89A














